ODTX
Odyssey Therapeutics, Inc.
20.99
+0.99 (+4.95%)
52w low 15.10
29.05 high
42.2% of range
Financial Analysis
| Ratio | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Profitability | |||||
| Operating Margin | -- | -12,867.8% | -3,023.8% | -5,415.2% | |
| EBITDA Margin | -- | -11,595.8% | -2,764.8% | -4,860.4% | |
| Net Margin | -- | -12,144.5% | -2,891.8% | -4,994.9% | |
| FCF Margin | -- | -11,358.1% | -2,643.9% | -4,391.8% | |
| Returns | |||||
| Return on Equity | 86.2% | 47.9% | 33.8% | 30.4% | |
| Return on Assets | -39.3% | -44.0% | -65.5% | -55.1% | |
| Return on Inv Capital | 88.9% | 47.8% | 33.8% | 30.4% | |
| Liquidity | |||||
| Current Ratio | 10.91x | 8.72x | 4.77x | 7.20x | |
| Quick Ratio | 10.91x | 8.72x | 4.77x | 7.20x | |
| Cash Ratio | 10.57x | 2.38x | 2.08x | 1.57x | |
| Leverage | |||||
| Debt / Equity | -0.29x | -0.13x | -0.08x | -0.06x | |
| Interest Coverage | -426.21x | -373.60x | -7157.44x | -8797.47x | |
| Equity Multiplier | -2.19x | -1.09x | -0.52x | -0.55x | |
| Efficiency | |||||
| Asset Turnover | 0.00x | 0.00x | 0.02x | 0.01x | |
| Effective Tax Rate | -0.3% | -0.4% | -0.4% | 0.6% | |
| Op CF / Net Income | 0.80x | 0.90x | 0.91x | 0.87x | |
| Investment | |||||
| Capex / Revenue | -- | 487.6% | 17.1% | 41.4% | |
| R&D / Revenue | -- | 10,827.3% | 2,517.4% | 4,254.6% | |
| SG&A / Revenue | -- | 2,140.5% | 606.4% | 1,260.6% | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-33.5%